Assunta De Rienzo

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Corrigendum to ‘Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype’ [Journal of Thoracic Oncology Volume 21 Issue 4 (2026) 103529]

  Journal of Thoracic Oncology · 2026-05-01

• Abstract CT063: An EphA2-targeting Bicycle Drug Conjugate (BDC), BT5528, in combination with nivolumab in patients (pts) with advanced solid tumors: Results from a Phase 1/2 study

  Cancer Research · 2026-04-17

• Abstract 4518: Preclinical assessment of BT5528 anti-tumor activity in patient-derived xenograft (PDX) models of pancreatic ductal adenocarcinoma (PDAC).

  Cancer Research · 2026-04-03

• Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype

  Journal of Thoracic Oncology · 2025-11-28 · 4 citations

• 414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer

  ESMO Open · 2025-05-01

• 647P EphA2-targeting bicycle toxin conjugate (BTC) BT5528 in patients (pts) with advanced solid tumors: A phase I/II study

  Annals of Oncology · 2024-09-01 · 4 citations